Antibacterial Discovery and Development: From Gene to Product and Back

Abstract

Concern over the reports of antibiotic-resistant bacterial infections in hospitals and in the community has been publicized in the media, accompanied by comments on the risk that we may soon run out of antibiotics as a way to control infectious disease. Infections caused byEnterococcus faecium, Staphylococcus aureus, Klebsiellaspecies,Clostridium difficile, Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, and otherEnterobacteriaceaespecies represent a major public health burden. Despite the pharmaceutical sector’s lack of interest in the topic in the last decade, microbial natural products continue to represent one of the most interesting sources for discovering and developing novel antibacterials. Research in microbial natural product screening and development is currently benefiting from progress that has been made in other related fields (microbial ecology, analytical chemistry, genomics, molecular biology, and synthetic biology). In this paper, we review how novel and classical approaches can be integrated in the current processes for microbial product screening, fermentation, and strain improvement.